How much does the Rain Oncology Securities Settlement pay?

Estimated payout: From $0.91. The total settlement fund is $7.3M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.

Do I need proof of purchase for the Rain Oncology Securities Settlement?

Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.

Is the Rain Oncology Securities Settlement notice real, or a scam?

Claims are filed at rainoncologysettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.

When will payments from the Rain Oncology Securities Settlement be sent?

Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. Payments cannot be issued until the court grants final approval and any appeals are resolved.

Claims closedsecurities

Rain Oncology Securities Settlement

From $0.91

This settlement is closed to new claims. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →

What happened

Rain Oncology and its executives allegedly made misrepresentations and omissions about the company's development and commercialization of milademetan between April 2021 and May 2023. The defendants violated federal securities laws by making false or misleading statements in public filings. The defendants deny any wrongdoing.

Do you qualify?

Anyone who purchased Rain Oncology, Inc. common stock between April 23, 2021 and May 19, 2023, inclusive.

How to file

Submit a completed Proof of Claim and Release Form to participate in the settlement and claim your share of the settlement fund. The form requires documentation of your stock purchases and sales. Contact Lead Counsel Adam M. Apton at Levi & Korsinsky, LLP for more information.

Common questions

How much does the Rain Oncology Securities Settlement pay?: Estimated payout: From $0.91. The total settlement fund is $7.3M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
Do I need proof of purchase for the Rain Oncology Securities Settlement?: Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.
Is the Rain Oncology Securities Settlement notice real, or a scam?: Claims are filed at rainoncologysettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
When will payments from the Rain Oncology Securities Settlement be sent?: Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. Payments cannot be issued until the court grants final approval and any appeals are resolved.

Who's involved

Counsel for plaintiffs

Adam M. AptonLevi & Korsinsky, LLP

Parties and counsel from the public court docket. Listing an attorney here isn't an endorsement, and ClaimWatch isn't affiliated with any of them.

In the news

Headlines via NewsAPI. ClaimWatch isn't affiliated with these publications.

New to class actions?

This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.

More securities settlements

View all →

August 28, 2026securities

Revance Securities Settlement

Revance Therapeutics and its executives made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the tender offer and merger transaction with Crown Laboratories, Inc., allegedly violating federal securities laws. Defendants deny any wrongdoing or liability.

Not yet determinable; depends on number of valid claims submitted

September 24, 2026securities

Biogen Securities Litigation Settlement

Biogen Inc. investors have settled a securities litigation case for $18.9 million in cash. The settlement resolves claims related to purchases of Biogen common stock during the specified class period.

October 6, 2026securities

NJ Bureau of Securities Settlement with Credit Suisse

Credit Suisse allegedly violated New Jersey Securities Law by making materially false and misleading statements regarding RMBS trust certificates and engaging in fraudulent practices. On October 24, 2022, the court entered a consent order requiring Credit Suisse to pay $300 million in restitution to investors. Credit Suisse neither admitted nor denied the allegations.

October 7, 2026securities

Stitch Fix Securities Litigation Settlement

Stitch Fix, Inc. is settling a securities class action lawsuit without admitting wrongdoing. The Lead Plaintiffs alleged that Stitch Fix issued misleading statements about its business, and shareholders who purchased the stock during the class period suffered damages as a result.